Progesterone Receptor Integrates the Effects of Mutated MED12 and Altered DNA Methylation to Stimulate RANKL Expression and Stem Cell Proliferation in Uterine Leiomyoma

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2018 Dec 13

PMID 30538295

Citations 21

Authors

Shimeng Liu

Ping Yin

Stacy A Kujawa

John S Coon 5th

Ijeoma Okeigwe

Serdar E Bulun

Affiliations

Soon will be listed here.

Abstract

Progesterone and its receptor, PR, are essential for uterine leiomyoma (LM, a.k.a., fibroid) tumorigenesis, but the underlying cellular and molecular mechanisms remain unclear. The receptor activator of NF-κB (RANKL) was recently identified as a novel progesterone/PR-responsive gene that plays an important role in promoting LM growth. Here, we used RANKL as a representative gene to investigate how steroid hormone, genetic, and epigenetic signals are integrated to regulate LM stem cell (LSC) function. We demonstrated that RANKL specifically upregulates LSC proliferation through activation of Cyclin D1. RANKL gene transcription was robustly induced by the progesterone agonist R5020, leading to a dramatically higher RANKL expression in LM compared to adjacent myometrial (MM) tissue. MethylCap-Seq revealed a differentially methylated region (DMR) adjacent to the distal PR-binding site (PRBS) 87 kb upstream of the RANKL transcription start site. Hypermethylation of the DMR inhibited recruitment of PR to the adjacent PRBS. Luciferase assays indicated that the DMR and distal PRBS constitute a novel RANKL distal regulatory element that actively regulates RANKL expression. Furthermore, MED12 physically interacts with PR in LM tissue. The interaction between MED12 and PR, binding of PR and MED12 to PRBS, and RANKL gene expression are significantly higher in LM containing a distinct MED12 mutation (G44D) than in LM with wild-type MED12. In summary, our findings suggest that DNA methylation and MED12 mutation together constitute a complex regulatory network that affects progesterone/PR-mediated RANKL gene expression, with an important role in activating stem cell proliferation and fibroid tumor development.

Citing Articles

Establishment of a 3D spheroid culture system to evaluate the responsiveness of uterine leiomyoma cells to female hormones.

Sakai T, Sato S, Tamehisa T, Takasaki H, Kajimura T, Tamura I Reprod Med Biol. 2025; 24(1):e12627.

PMID: 39845479 PMC: 11751880. DOI: 10.1002/rmb2.12627.

Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.

Wlodarczyk M, Ciebiera M, Nowicka G, Lozinski T, Ali M, Al-Hendy A Nutrients. 2024; 16(4).

PMID: 38398883 PMC: 10893337. DOI: 10.3390/nu16040559.

TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma.

Yang L, Fan Q, Wang J, Yang X, Yuan J, Li Y Cell Death Discov. 2023; 9(1):185.

PMID: 37344459 PMC: 10284899. DOI: 10.1038/s41420-023-01484-0.

Progesterone Signaling and Uterine Fibroid Pathogenesis; Molecular Mechanisms and Potential Therapeutics.

Ali M, Ciebiera M, Vafaei S, Alkhrait S, Chen H, Chiang Y Cells. 2023; 12(8).

PMID: 37190026 PMC: 10136461. DOI: 10.3390/cells12081117.

A View on Uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.

Koltsova A, Efimova O, Pendina A Int J Mol Sci. 2023; 24(6).

PMID: 36982825 PMC: 10056617. DOI: 10.3390/ijms24065752.

References

Yin P, Ono M, Moravek M, Coon 5th J, Navarro A, Monsivais D . Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo. J Clin Endocrinol Metab. 2015; 100(4):E601-6. PMC: 4399295. DOI: 10.1210/jc.2014-2134. View

Ono M, Yin P, Navarro A, Moravek M, Coon 5th J, Druschitz S . Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A. 2013; 110(42):17053-8. PMC: 3801037. DOI: 10.1073/pnas.1313650110. View

Shen L, Shao N, Liu X, Nestler E . ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics. 2014; 15:284. PMC: 4028082. DOI: 10.1186/1471-2164-15-284. View

Navarro A, Yin P, Monsivais D, Lin S, Du P, Wei J . Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS One. 2012; 7(3):e33284. PMC: 3302826. DOI: 10.1371/journal.pone.0033284. View

Tanos T, Sflomos G, Echeverria P, Ayyanan A, Gutierrez M, Delaloye J . Progesterone/RANKL is a major regulatory axis in the human breast. Sci Transl Med. 2013; 5(182):182ra55. DOI: 10.1126/scitranslmed.3005654. View

Heinz S, Benner C, Spann N, Bertolino E, Lin Y, Laslo P . Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010; 38(4):576-89. PMC: 2898526. DOI: 10.1016/j.molcel.2010.05.004. View

Fan X, Roy E, Murphy T, Nanes M, Kim S, Pike J . Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J Cell Biochem. 2004; 93(4):807-18. DOI: 10.1002/jcb.20217. View

Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L . RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nat Med. 2016; 22(8):933-9. DOI: 10.1038/nm.4118. View

Chen W, Roeder R . The Mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation. Nucleic Acids Res. 2007; 35(18):6161-9. PMC: 2094069. DOI: 10.1093/nar/gkm661. View

10.

Klug M, Rehli M . Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics. 2007; 1(3):127-30. DOI: 10.4161/epi.1.3.3327. View

11.

Diaz Flaque M, Galigniana N, Beguelin W, Vicario R, Proietti C, Russo R . Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Res. 2013; 15(6):R118. PMC: 3978912. DOI: 10.1186/bcr3587. View

12.

Hu Y, Sun M, Nadiminty N, Lou W, Pinder E, Gao A . Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun. 2008; 370(3):440-4. PMC: 2950805. DOI: 10.1016/j.bbrc.2008.03.106. View

13.

Joshi P, Jackson H, Beristain A, Di Grappa M, Mote P, Clarke C . Progesterone induces adult mammary stem cell expansion. Nature. 2010; 465(7299):803-7. DOI: 10.1038/nature09091. View

14.

Acevedo M, Kraus W . Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates. Mol Cell Biol. 2002; 23(1):335-48. PMC: 140681. DOI: 10.1128/MCB.23.1.335-348.2003. View

15.

Borahay M, Al-Hendy A, Kilic G, Boehning D . Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy. Mol Med. 2015; 21:242-56. PMC: 4503645. DOI: 10.2119/molmed.2014.00053. View

16.

Hsu P, Hsu H, Hsiao T, Ye Z, Wang E, Profit A . Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells. Oncogene. 2015; 35(18):2379-89. PMC: 4865474. DOI: 10.1038/onc.2015.298. View

17.

Fondell J, Ge H, Roeder R . Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A. 1996; 93(16):8329-33. PMC: 38670. DOI: 10.1073/pnas.93.16.8329. View

18.

Boyes J, Bird A . DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell. 1991; 64(6):1123-34. DOI: 10.1016/0092-8674(91)90267-3. View

19.

Bonifacino J, Gershlick D, DellAngelica E . Immunoprecipitation. Curr Protoc Cell Biol. 2016; 71. DOI: 10.1002/cpcb.3. View

20.

Delgado-Calle J, Sanudo C, Fernandez A, Garcia-Renedo R, Fraga M, Riancho J . Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. Epigenetics. 2011; 7(1):83-91. PMC: 3337833. DOI: 10.4161/epi.7.1.18753. View